Literature DB >> 23900153

Inhibition of apoptosis by knockdown of caspase-3 with siRNA in rat bone marrow mesenchymal stem cells.

Ping Hua1, Li-Bao Liu, Jia-Liang Liu, Meng Wang, Hui-Qi Jiang, Kuan Zeng, Yan-Qi Yang, Song-Ran Yang.   

Abstract

Transplantation of bone marrow mesenchymal stem cells is a promising new strategy for the repair of infarcted cardiac tissue. However, the majority of transplanted bone marrow mesenchymal stem cells (BMSCs) die soon after transplantation, due in part to oxidative stress in the ischemic region. Oxidative stress is known to induce apoptosis through the activation of caspase-3. The aim of this study is to determine whether small interfering RNA targeting caspase-3 can inhibit the apoptosis of rat BMSCs in vitro. Caspase-3 siRNA expression vectors were prepared and transfected into rat BMSCs in the presence of liposomes. Western blot assay and real-time polymerase chain reaction (RT-PCR) were performed to detect caspase-3 expression. A retrovirus packaging system was employed to package 293FT cells producing caspase-3 siRNA virus, which were transfected into rat BMSCs. Those stably expressing caspase-3 siRNA were screened by Western blot assay and RT-PCR to determine caspase-3 expression levels. Stable transfection of caspase-3 siRNA significantly decreased caspase-3 protein (0.26 ± 0.001 vs. 0.42 ± 0.004, P < 0.05) and mRNA expression (0.19 ± 0.002 vs. 1, P < 0.05) in BMSCs compared to non-transfected BMSCs. Cells were incubated in H2O2 to induce apoptosis, which was detected by TUNEL staining, and BMSC morphology was not altered by either transient or stable transfection of caspase-3 siRNA. H2O2-induced apoptosis of BMSCs stably transfected with caspase-3 siRNA was dramatically reduced compared to that of normal BMSCs (11.0 ± 3.2 vs. 25.8 ± 4.2, P < 0.05). Caspase-3 knockdown BMSCs are thus more resistant to apoptosis than normal BMSCs, potentially increasing their survival rates under conditions that cause oxidative stress.

Entities:  

Keywords:  BMSC; Cell therapy; myocardial infarction; oxidative stress; stable transfection

Mesh:

Substances:

Year:  2013        PMID: 23900153     DOI: 10.1177/1535370213497320

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  6 in total

1.  Roles of TRPV4 and piezo channels in stretch-evoked Ca2+ response in chondrocytes.

Authors:  Genlai Du; Li Li; Xinwang Zhang; Jianbing Liu; Jianqing Hao; Jianjun Zhu; Hao Wu; Weiyi Chen; Quanyou Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2019-12-02

2.  Protective effect of Photobiomodulation Therapy and Bone Marrow Stromal Stem Cells Conditioned Media on Pheochromocytoma Cell Line 12 Against Oxidative Stress Induced by Hydrogen Peroxide.

Authors:  Shahrokh Khoshsirat; Hojjat Allah Abbaszadeh; Maryam Sadat Khoramgah; Shahram Darabi; Vahid Mansouri; Navid Ahmady-Roozbahany; Behnaz Ahrabi; Maryam Bahrami; Saeed Vafaee; Foozhan Tahmasebinia; Mahnaz Poor Hassan
Journal:  J Lasers Med Sci       Date:  2019-07-06

Review 3.  State of the field: cellular and exosomal therapeutic approaches in vascular regeneration.

Authors:  Evan Paul Tracy; Virginia Stielberg; Gabrielle Rowe; Daniel Benson; Sara S Nunes; James B Hoying; Walter Lee Murfee; Amanda Jo LeBlanc
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-02-18       Impact factor: 4.733

4.  [Effects of tumor necrosis factor-α on osteogenic differentiation and Notch signaling pathway in human periodontal ligament stem cells].

Authors:  Yu Ma; Shu-Hui Li; Xin-Xin Ding; Pei-Ling Wu
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2018-04-01

Review 5.  Advancing precision medicines for ocular disorders: Diagnostic genomics to tailored therapies.

Authors:  Priyalakshmi Panikker; Shomereeta Roy; Anuprita Ghosh; B Poornachandra; Arkasubhra Ghosh
Journal:  Front Med (Lausanne)       Date:  2022-07-15

Review 6.  Regulation of the mitochondrial reactive oxygen species: Strategies to control mesenchymal stem cell fates ex vivo and in vivo.

Authors:  Chenxia Hu; Lingfei Zhao; Conggao Peng; Lanjuan Li
Journal:  J Cell Mol Med       Date:  2018-08-30       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.